Wednesday, October 19, 2016

Quinocort Cream





1. Name Of The Medicinal Product

QUINOCORT™ CREAM


2. Qualitative And Quantitative Composition








Potassium Hydroxyquinoline Sulphate BP




0.5%




Hydrocortisone BP




1.0%



3. Pharmaceutical Form



Quinocort Cream is a faintly yellow vanishing cream. It is intended for topical use only.


4. Clinical Particulars



4.1 Therapeutic Indications



The treatment of infected eczema, intertrigo and other steroid-responsive dermatoses where anti-infective cover is appropriate.



4.2 Posology And Method Of Administration



Route of administration: For topical use only.



Adults, children and the elderly



By gentle massage over all the affected area two to three times daily.



4.3 Contraindications



Patients with known sensitivity or intolerance to any of the ingredients.



4.4 Special Warnings And Precautions For Use



Contact with eyes and other mucosal surfaces should be avoided. Caution should be exercised when using this preparation in infants. Long term continuous topical therapy should be avoided in infants - adrenal suppression can occur even without occlusion.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



Not applicable.



4.6 Pregnancy And Lactation



In pregnant animals administration of corticosteroids can cause abnormalities of foetal development. The relevance of this finding in human beings has not been established. However, topical steroids should not be used extensively in pregnancy i.e. in large amounts for long periods.



4.7 Effects On Ability To Drive And Use Machines



Not applicable.



4.8 Undesirable Effects



Not applicable.



4.9 Overdose



Not applicable.



5. Pharmacological Properties



Hydrocortisone provides anti-inflammatory action yet is the least potent topical corticosteroid available. Potassium hydroxyquinoline sulphate provides broad spectrum antibacterial and anticandidal activity. The combination facilitates treatment of steroid-responsive dermatoses where complication by infection with bacteria or yeasts is evident suspected, or a possibility.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Lactic Acid BP, White Soft Paraffin BP, Edetic Acid BP, Sodium Acid Phosphate BP, Maize Starch BP, cetyl stearyl alcohol, sodium cetyl stearyl sulphate, PEG 40 castor oil, Chlorocresol BP, Purified Water BP.



6.2 Incompatibilities



Not applicable.



6.3 Shelf Life



Two years.



6.4 Special Precautions For Storage



Quinocort Cream should be stored in a cool, dry place avoiding extremes of temperature i.e. not less than 5°C and not more than 30°C.



6.5 Nature And Contents Of Container



Quinocort Cream is available in heat sealed low density polyethylene tubes with flush fitting cap containing 30 g of product. Each tube is cartoned and contains a patient information leaflet.



6.6 Special Precautions For Disposal And Other Handling



For topical use only.



8. Marketing Authorisation Number(S)



0291/0014.



10. Date Of Revision Of The Text



May 1995.



Legal category


POM.





No comments:

Post a Comment